Cases 1 - 7 of 7
Astellas Pharma Inc. et al v. Qilu Pharma, Inc. et al
as 1:2023cv00022
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Defendant:
Qilu Pharma, Inc. and Qilu Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Qilu Pharmaceutical Co., Ltd. et al
as 1:2021cv00929
Plaintiff:
Pfizer Inc., Warner-Lambert Company LLC and PF Prism IMB B.V.
Defendant:
Qilu Pharma, Inc. and Qilu Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Qilu Pharma, Inc. et al
as 1:2019cv00754
Defendant:
Qilu Pharma, Inc. and Qilu Pharmaceutical Co., Ltd.
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Cause Of Action: 35 U.S.C. § 271
Millennium Pharmaceuticals, Inc. v. Qilu Pharmaceutical Co., Ltd. et al
as 1:2017cv01830
Plaintiff:
Millennium Pharmaceuticals, Inc.
Defendant:
Qilu Pharmaceutical Co., Ltd. and Qilu Pharma Inc.
Cause Of Action: 35 U.S.C. § 271
Onyx Therapeutics, Inc. v. Qilu Pharma, Inc. et al
as 1:2017cv01235
Plaintiff:
Onyx Therapeutics, Inc.
Defendant:
Qilu Pharma, Inc. and Qilu Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Onyx Therapeutics, Inc. v. Qilu Pharma, Inc. et al
as 1:2016cv01013
Plaintiff:
Onyx Therapeutics, Inc.
Defendant:
Qilu Pharma, Inc. and Qilu Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
